Feedback / Questions
lasmecabtagene timgedleucel (UCART22) - Cellectis
Campath (alemtuzumab) - Sanofi
http://clinicaltrials.gov/ct2/show/NCT04150497
Jun 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next